the best advice I can give to better formulate the various possibilities is to take into account in the most absolute that any strategy of Treagus regardless of the wishes or needs of US ARMY. I go back to remember that until today the US Army was the largest financier of NNZ-2566 or Trofinetide; it is difficult, if not impossible, to imagine a future scenario that does not take into account this overwhelming position of US ARMY that circumstances claim to be the first candidate to optionate NNZ-2591; It is a fact that for five years now NNZ-2591 is under a preclinical examination at the hands of the same US ARMY. the recent update of the relevant European patent keeps track of it.
Hello
Add to My Watchlist
What is My Watchlist?
